デジタルバイオマニュファクチャリング市場：展開、用途、最終用途別-2025-2030年の世界予測

デジタルバイオマニュファクチャリング市場の2023年の市場規模は173億5,000万米ドルで、2024年には189億7,000万米ドルに達すると予測され、CAGR 9.67％で成長し、2030年には331億2,000万米ドルに達すると予測されています。

デジタルバイオマニュファクチャリングは、医薬品、バイオ燃料、その他の生化学などの生物学的製品の生産プロセスへのデジタル技術の統合を指します。この統合は、効率性、精密性、拡張性を高め、従来のバイオテクノロジーとインダストリー4.0のギャップを埋める。デジタルバイオマニュファクチャリングの必要性は、個別化医療、持続可能な生産技術、世界の健康課題に対応するためのバイオプロセスにおける迅速な技術革新に対する需要の高まりから生じています。そのアプリケーションは医薬品、農業、飲食品、環境科学など多岐にわたり、リアルタイムでのプロセスモニタリングや予測分析などの進歩を促進しています。究極のエンドユーザーは製薬会社から農業、エネルギー部門まで多岐にわたる。主な成長要因としては、データ分析、機械学習、自動化における技術的進歩のほか、バイオテクノロジーへの投資の増加、持続可能な生産方法に対する政府の支援などが挙げられます。デジタルバイオマニュファクチャリングがオーダーメイド治療のための生産を最適化できる個別化医療には機会があふれています。企業は、このような機会を活用するために、堅牢なデジタル・インフラを開発し、セクターを超えたコラボレーションを促進することに注力すべきです。しかし、この市場は、技術導入の初期コストの高さ、データプライバシーに関する懸念、バイオテクノロジーとデジタル技術の両方に精通した熟練人材の不足といった課題に直面しています。的を絞った人材育成と戦略的パートナーシップを通じてこれらの限界に対処することが極めて重要になります。イノベーションにとって重要な分野には、人工知能を活用したバイオプロセスの最適化、IoTを活用したバイオ製造ワークフロー、バイオテクノロジーにおけるサプライチェーンの透明性を高めるブロックチェーンなどがあります。研究開発は、オペレーションコストの削減、製品の歩留まりと品質の向上に重点を置くべきです。市場の性質はダイナミックで競争が激しく、急速な技術進歩が業界標準を絶えず塗り替えています。利害関係者は、この進化する状況の中で成長と競争力を維持するために、規制状況の変化と技術革新の両方に適応し、機敏であり続けなければならないです。

市場力学：急速に進化するデジタルバイオマニュファクチャリング市場の主要市場インサイトを公開

デジタルバイオマニュファクチャリング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • デジタルバイオマニュファクチャリングプロセスの重要な用途
  • 生物製剤の需要増とバイオ製造プロセス強化の必要性
  • バイオ製造施設の運営拡大
• 市場抑制要因
  • デジタルバイオマニュファクチャリング技術の展開に必要なコストの高さ
• 市場機会
  • バイオマニュファクチャリングにおけるビッグデータとデジタルツインの新たな役割
  • スマート工場開発における政府のイニシアティブと投資の拡大
• 市場の課題
  • デジタルバイオマニュファクチャリングに関連する移行とサイバーセキュリティの課題

ポーターのファイブフォースデジタルバイオマニュファクチャリング市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、デジタルバイオマニュファクチャリング市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：デジタルバイオマニュファクチャリング市場における外部からの影響の把握

外部マクロ環境要因は、デジタルバイオマニュファクチャリング市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析デジタルバイオマニュファクチャリング市場における競合情勢の把握

デジタルバイオマニュファクチャリング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスデジタルバイオマニュファクチャリング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、デジタルバイオマニュファクチャリング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨デジタルバイオマニュファクチャリング市場における成功への道筋を描く

デジタルバイオマニュファクチャリング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • デジタルバイオマニュファクチャリングプロセスの重要な応用
    • 生物製剤の需要増加とバイオ製造プロセス強化の必要性
    • バイオ製造施設の運営拡大
  • 抑制要因
    • デジタルバイオマニュファクチャリング技術の導入には高額なコストがかかる
  • 機会
    • バイオ製造におけるビッグデータとデジタルツインの新たな役割
    • スマートファクトリー開発に対する政府の取り組みと投資の増加
  • 課題
    • デジタルバイオマニュファクチャリングに関連する移行とサイバーセキュリティの課題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 デジタルバイオマニュファクチャリング市場：展開別

• クラウド
• オンプレミス

第7章 デジタルバイオマニュファクチャリング市場：用途別

• 抗体
• 細胞・遺伝子治療
• タンパク質
• ワクチン

第8章 デジタルバイオマニュファクチャリング市場：最終用途別

• 学術調査機関
• バイオ医薬品企業
• 契約調査機関

第9章 南北アメリカのデジタルバイオマニュファクチャリング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のデジタルバイオマニュファクチャリング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのデジタルバイオマニュファクチャリング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 3M Company
• ABB Ltd.
• Agilent Technologies, Inc.
• bioMerieux SA
• Bota Biosciences, Ltd.
• CellPort Software
• Culture Biosciences, Inc.
• Cytiva（Global Life Sciences Solutions USA LLC）
• Debut Biotechnology
• Donaldson Company, Inc.
• Emerson Electric Co.
• FabricNano
• GE Healthcare
• Indegene Limited
• OVO Biomanufacturing
• Samsung Biologics
• Sanofi SA
• Sartorius AG
• Shimadzu Corp.
• Siemens AG
• Thermo Fisher Scientific Inc.
• Waters Corp.
• 64xBio

LIST OF FIGURES

• FIGURE 1. DIGITAL BIOMANUFACTURING MARKET RESEARCH PROCESS
• FIGURE 2. DIGITAL BIOMANUFACTURING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. DIGITAL BIOMANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. DIGITAL BIOMANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DIGITAL BIOMANUFACTURING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DIGITAL BIOMANUFACTURING MARKET DYNAMICS
• TABLE 7. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CLOUD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY ON-PREMISES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL & GENE THERAPIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 29. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 30. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 46. CHINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 47. CHINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. CHINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 49. INDIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 50. INDIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. INDIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 101. ITALY DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 102. ITALY DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. ITALY DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 113. POLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 114. POLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. POLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 116. QATAR DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 117. QATAR DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. QATAR DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 146. DIGITAL BIOMANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 147. DIGITAL BIOMANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023

The Digital Biomanufacturing Market was valued at USD 17.35 billion in 2023, expected to reach USD 18.97 billion in 2024, and is projected to grow at a CAGR of 9.67%, to USD 33.12 billion by 2030.

Digital biomanufacturing refers to the integration of digital technologies into the production processes of biological products, such as pharmaceuticals, biofuels, and other biochemicals. This integration enhances efficiency, precision, and scalability, bridging the gap between traditional biotechnology and Industry 4.0. The necessity for digital biomanufacturing arises from the growing demand for personalized medicine, sustainable production techniques, and the need for rapid innovation in bioprocessing to meet global health challenges. Its applications are vast, encompassing pharmaceuticals, agriculture, food and beverage, and environmental sciences, facilitating advancements like real-time process monitoring and predictive analytics. Ultimate end-users are diverse, ranging from pharmaceutical companies to agricultural and energy sectors. Key growth factors include technological advancements in data analytics, machine learning, and automation, as well as increased investments in biotechnology and governmental support for sustainable production methods. Opportunities abound in personalized medicine, where digital biomanufacturing can optimize production for tailored therapies. Companies should focus on developing robust digital infrastructures and fostering collaborations across sectors to capitalize on these opportunities. However, the market faces challenges such as high initial costs of technology implementation, data privacy concerns, and a shortage of skilled personnel competent in both biotechnology and digital technologies. Addressing these limitations through targeted workforce development and strategic partnerships will be crucial. Critical areas for innovation include artificial intelligence-driven bioprocess optimization, IoT-based biomanufacturing workflows, and blockchain for supply chain transparency in biotech. Research and development should focus on reducing operational costs and enhancing product yield and quality. The nature of the market is dynamic and highly competitive, with rapid technological advancements continually reshaping industry standards. Stakeholders must remain agile, adapting to both regulatory changes and technological innovations to sustain growth and competitiveness in this evolving landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Digital Biomanufacturing Market

The Digital Biomanufacturing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Significant applications of the digital biomanufacturing process
  • Increased demand for biologics and need for enhanced biomanufacturing process
  • Expanding operations of biomanufacturing facilities
• Market Restraints
  • High costs required for the deployment of digital biomanufacturing technologies
• Market Opportunities
  • Emerging roles of big data and digital twin in biomanufacturing
  • Growing government initiatives and investments in smart factory development
• Market Challenges
  • Transition and cybersecurity challenges associated with digital biomanufacturing

Porter's Five Forces: A Strategic Tool for Navigating the Digital Biomanufacturing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Digital Biomanufacturing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Digital Biomanufacturing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Digital Biomanufacturing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Digital Biomanufacturing Market

A detailed market share analysis in the Digital Biomanufacturing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Digital Biomanufacturing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Digital Biomanufacturing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Digital Biomanufacturing Market

A strategic analysis of the Digital Biomanufacturing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Digital Biomanufacturing Market, highlighting leading vendors and their innovative profiles. These include 3M Company, ABB Ltd., Agilent Technologies, Inc., bioMerieux SA, Bota Biosciences, Ltd., CellPort Software, Culture Biosciences, Inc., Cytiva (Global Life Sciences Solutions USA LLC), Debut Biotechnology, Donaldson Company, Inc., Emerson Electric Co., FabricNano, GE Healthcare, Indegene Limited, OVO Biomanufacturing, Samsung Biologics, Sanofi SA, Sartorius AG, Shimadzu Corp., Siemens AG, Thermo Fisher Scientific Inc., Waters Corp., and 64xBio.

Market Segmentation & Coverage

This research report categorizes the Digital Biomanufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Deployment, market is studied across Cloud and On-premises.
• Based on Application, market is studied across Antibodies, Cell & Gene Therapies, Proteins, and Vaccines.
• Based on End-use, market is studied across Academic & Research Institutes, Biopharmaceutical Companies, and Contract Research Organizations.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Significant applications of the digital biomanufacturing process
    • 5.1.1.2. Increased demand for biologics and need for enhanced biomanufacturing process
    • 5.1.1.3. Expanding operations of biomanufacturing facilities
  • 5.1.2. Restraints
    • 5.1.2.1. High costs required for the deployment of digital biomanufacturing technologies
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging roles of big data and digital twin in biomanufacturing
    • 5.1.3.2. Growing government initiatives and investments in smart factory development
  • 5.1.4. Challenges
    • 5.1.4.1. Transition and cybersecurity challenges associated with digital biomanufacturing
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Digital Biomanufacturing Market, by Deployment

• 6.1. Introduction
• 6.2. Cloud
• 6.3. On-premises

7. Digital Biomanufacturing Market, by Application

• 7.1. Introduction
• 7.2. Antibodies
• 7.3. Cell & Gene Therapies
• 7.4. Proteins
• 7.5. Vaccines

8. Digital Biomanufacturing Market, by End-use

• 8.1. Introduction
• 8.2. Academic & Research Institutes
• 8.3. Biopharmaceutical Companies
• 8.4. Contract Research Organizations

9. Americas Digital Biomanufacturing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Digital Biomanufacturing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Digital Biomanufacturing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3M Company
• 2. ABB Ltd.
• 3. Agilent Technologies, Inc.
• 4. bioMerieux SA
• 5. Bota Biosciences, Ltd.
• 6. CellPort Software
• 7. Culture Biosciences, Inc.
• 8. Cytiva (Global Life Sciences Solutions USA LLC)
• 9. Debut Biotechnology
• 10. Donaldson Company, Inc.
• 11. Emerson Electric Co.
• 12. FabricNano
• 13. GE Healthcare
• 14. Indegene Limited
• 15. OVO Biomanufacturing
• 16. Samsung Biologics
• 17. Sanofi SA
• 18. Sartorius AG
• 19. Shimadzu Corp.
• 20. Siemens AG
• 21. Thermo Fisher Scientific Inc.
• 22. Waters Corp.
• 23. 64xBio